Comparative analysis of ascorbic acid in human milk and infant formula using varied milk delivery systems.

Int Breastfeed J

Department of Biochemistry, Agricultural Experiment Station, University of Nevada, Reno, NV, USA.

Published: August 2008

Background: The expression of human milk for later use is on the rise. Bottle systems are used to deliver the expressed milk. Research has shown that storage of both human milk and artificial baby milk, or infant formula, leads to a loss of ascorbic acid (commonly called Vitamin C). As milk is removed from the bottle during feeding and replaced by ambient air, it is unknown if loss of ascorbic acid occurs during the course of a feeding. The purpose of this study is to investigate the effect of the milk delivery system on levels of ascorbic acid in human milk and infant formula. The objectives are to 1) determine changes in ascorbic acid concentration during a 20 minute "feed," 2) determine if there is a difference in ascorbic acid concentration between delivery systems, and 3) evaluate if any differences are of clinical importance.

Methods: Commonly available bottles were used for comparison of bottle delivery systems. Mature human milk was standardized to 42 mg/L of ascorbic acid. Infant formula with iron and infant formula with docosahexanoic acid were used for the formula samples. Each sample was analyzed for ascorbic acid concentration at baseline (0), 5, 10, 15, and 20 minutes. Each collection of samples was completed in triplicate. Samples were analyzed for ascorbic acid using normal-phase high performance liquid chromatography.

Results: Ascorbic acid concentration declined in all bottle systems during testing, Differences between the bottle systems were noted. Ascorbic acid concentrations declined to less than 40% of recommended daily intake for infants in 4 of the bottles systems at the 20 minute sampling.

Conclusion: The bottle systems used in this study had measurable decreases in the mean concentration of ascorbic acid. More research is needed to determine if the observed decreases are related to lower plasma ascorbic acid concentration in infants exclusively bottle fed. The decrease of ascorbic acid concentration observed in both human milk and infant formula using varied milk delivery systems may be of clinical importance. For infants who rely solely on bottle feeds there may be increased risk of deficiency. Bottle shape, size, and venting should be considered.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526073PMC
http://dx.doi.org/10.1186/1746-4358-3-19DOI Listing

Publication Analysis

Top Keywords

ascorbic acid
56
human milk
24
infant formula
24
acid concentration
24
milk infant
16
delivery systems
16
bottle systems
16
acid
15
ascorbic
14
milk
12

Similar Publications

Monitoring reactive nitrogen species (RNS) in complex biological media is essential for evaluating the health status of living organisms; however, biofouling on the sensor surface restricts its applications. To overcome this issue, we developed an antifouling electrochemical sensing platform using copper-platinum bimetallic nanoparticles/N-doped biomass porous carbon fibres (Cu-PtNPs/N-BCF) for directly detecting peroxynitrite anion (ONOO), a major type of RNS. Cyclic voltammetry measurements demonstrated that the Cu-PtNPs/N-BCF-2 nanocomposite, synthesised at a molar ratio of 1:1 between Co and Zn, exhibited exceptional electrocatalytic activity for ONOO oxidation.

View Article and Find Full Text PDF

The rise of various diseases demands the development of new agents with antioxidant, antimicrobial, anti-inflammatory, enzyme-inhibiting, and cytotoxic properties. In this study, heterocyclic Schiff base complexes of Cu(II) featuring a benzo[]thiophene moiety were synthesized and their biological activities evaluated. The complexes were characterized using FT-IR, UV-Vis, and EPR spectroscopy, TG-DTG analysis, magnetic moment measurements, molar conductivity measurements, and elemental analyses.

View Article and Find Full Text PDF

<b>Background and Objective:</b> Methotrexate is an anti-metabolic medication used to treat cancer. It causes oxidative stress in nerve tissue and has neurotoxic effects. A strong antioxidant and effective free radical scavenger is vitamin C.

View Article and Find Full Text PDF

: Cerebrovascular disease and dementia risk increases with age and lifetime risk is greater in women. Cerebrovascular dysfunction likely precedes cerebrovascular disease and dementia but the mechanisms are incompletely understood. We hypothesized that oxidative stress mediates cerebrovascular dysfunction with human aging.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!